Home Multimedia Podcasts ADVANCES IN DRUG DELIVERY AND TISSUE ENGINEERING ADVANCES IN DRUG DELIVERY AND TISSUE ENGINEERING April 10, 2008 – Interview with Robert Langer, Ph.D., Institute Professor, Chemical and Biomedical Engineering, MIT /wp-content/uploads/2018/09/gc198_4_10_2008.mp3 Brain cancerCancersDrug deliveryGenetic engineeringGenetic Engineering and BiotechnologyMedicine, Diagnosis, and TherapeuticsNanoparticlesNanotechnologyPharmacologyRegenerative engineeringSystemic conditionsTechnology and Computational BiologyTissue engineering Also of Interest UV-Damaged RNA in Daughter Cells Captured by Stress Granules StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Ricoh and ERS Genomics Sign CRISPR Licensing Agreement Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary AI Detects Cancer via DNA Repeats in Liquid Biopsies Related Media Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World Breathing Oxygen Back into the Biological Conversation Related Content UV-Damaged RNA in Daughter Cells Captured by Stress Granules StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Ricoh and ERS Genomics Sign CRISPR Licensing Agreement